Sun Pharma Subsidiary and Aclaris Therapeutics Inks Licensing Pact

As per exchange filing, Sun Pharmaceutical Industries Inc., a subsidiary of India's leading medicine manufacturer Sun Pharma, has entered into a licensing arrangement with Aclaris Therapeutics Inc. Based on the licensing agreement, Aclaris has...

Clarivate Widens Alliance with VeriSIM Life For Drug Development

Clarivate Plc, a worldwide leader in connecting people and companies to trusted knowledge to alter their environment, has announced the debut of the VeriSIM Life Translational Index on Cortellis Drug Discovery knowledge by Clarivate. Customers...

Takeda and BIRAC Join Hands To Foster Healthcare Innovation

Takeda announced the signing of a three-year Memorandum of Understanding (MOU) with the Biotechnology Industry Research Assistance Council (BIRAC), a public-sector business established by the Government of India's Department of Biotechnology...

India-UK Research: Easy Test to Combat Antibiotic Resistance

A new India-UK research project is testing an easy-to-use urinary tract infection (UTI) test to help determine the appropriate course of action and tackle the global threat of antimicrobial resistance (AMR). According to the British Medical Research

China NMPA Approves Everest Medicine's Zetomipzomib IND for Immune

Everest Medicines, a biopharmaceutical company focused on the development, production and commercialization of innovative medicines and vaccines, announced that China's National Medical

Vesalius Pharma Seeks Indian Pharma Export to Colombo

Colombo-based pharmaceutical company Vesalius Pharma, headquartered in Bogotá, has invited Indian companies to export children's multivitamins and antifreeze powder, among others.

NCISM Announces Regulations for Medical Research

The National Commission for the Indian System of Medicine (NCISM) has announced regulations to set standards for medical research in the Indian System of Medicine (ISM).

Granules' Sildenafil Oral Suspension FDA Approval for PAH

Granules India Limited announced that the US Food and Drug Administration (FDA) have approved an Abbreviated New Drug Application (ANDA) for sildenafil oral suspension submitted by its wholly owned foreign subsidiary, Granules Pharmaceuticals, Inc.

IU Researchers Advance Alzheimer's Study with New Brain Network Tools

Indiana University (IU) researchers are collaborating on a new approach that uses neuroimaging and network modelling tools previously developed to analyze the brains of patients in the clinic to study the progression of Alzheimer's disease in preclin

FDA Approval: Eli Lilly's Jaypirca for CLL/SLL After Prior Therapies

Eli Lilly and Company announced that the US Food and Drug Administration (FDA) has approved Jaypirca

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.